Protein-protein interaction networks suggest different targets have different propensities for triggering drug resistance

Systems and Synthetic Biology

Volumn 4, Issue 4, 2010, Pages 311-322

  Padiadpu, Jyothi ^a   Vashisht, Rohit ^a   Chandra, Nagasuma ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Emergence of resistance; Network analysis; Resistome

Indexed keywords

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 79953209990     PISSN: 18725325     EISSN: 18725333     Source Type: Journal    
DOI: 10.1007/s11693-011-9076-5     Document Type: Article

References (47)

1. Abbadi SH, Sameaa GA, Morlock G, Cooksey RC (2009) Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of mycobacterium tuberculosis. Int J Infect Dis 13(6): 673-678. doi: S1201-9712(08)01731-1[pii]10. 1016/j. ijid. 2008. 10. 006.
2. Alekshun MN, Levy SB (2007) Molecular mechanisms of antibacterial multidrug resistance. Cell 128(6): 1037-1050. doi: S0092-8674(07)00311-X[pii]10. 1016/j. cell. 2007. 03. 004.
3. Argyrou A, Jin L, Siconilfi-Baez L, Angeletti RH, Blanchard JS (2006) Proteome-wide profiling of isoniazid targets in mycobacterium tuberculosis. Biochemistry 45(47): 13947-13953. doi: 10. 1021/bi061874m.
4. Assenov Y, Ramirez F, Schelhorn S-E, Lengauer T, Albrecht M (2008) Computing topological parameters of biological networks. Bioinformatics 24(2): 282-284. doi: 10. 1093/bioinformatics/btm554.
5. Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5(2): 101-U115. doi: 10. 1038/nrg1272.
6. Barradell LB, Fitton A (1995) Artesunate: a review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs 50(4): 714-741.
7. Boshoff HI, Myers TG, Copp BR, McNeil MR, Wilson MA, Barry CE 3rd (2004) The transcriptional responses of mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J Biol Chem 279(38): 40174-40184. doi: 10. 1074/jbc. M406796200M406796200[pii].
8. Cabusora L, Sutton E, Fulmer A, Forst CV (2005) Differential network expression during drug and stress response. Bioinformatics 21(12): 2898-2905. doi: bti440[pii]10. 1093/bioinformatics/bti440.
9. Card GL, Peterson NA, Smith CA, Rupp B, Schick BM, Baker EN (2005) The crystal structure of rv1347c, a putative antibiotic resistance protein from mycobacterium tuberculosis, reveals a gcn5-related fold and suggests an alternative function in siderophore biosynthesis. J Biol Chem 280(14): 13978-13986. doi: M413904200[pii]10. 1074/jbc. M413904200.
10. Chen P, Gearhart J, Protopopova M, Einck L, Nacy CA (2006) Synergistic interactions of sq109, a new ethylene diamine, with front-line antitubercular drugs in vitro. J Antimicrob Chemother 58(2): 332-337. doi: dkl227[pii]10. 1093/jac/dkl227.
11. Chopra I, Brennan P (1997) Molecular action of anti-mycobacterial agents. Tuber Lung Dis 78(2): 89-98.
12. Colangeli R, Helb D, Vilcheze C, Hazbon MH, Lee CG, Safi H, Sayers B, Sardone I, Jones MB, Fleischmann RD, Peterson SN, Jacobs WR, Jr., Alland D (2007) Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein lsr2 in m. Tuberculosis. PLoS Pathog 3 (6): e87. doi: 06-PLPA-RA-0540[pii]10. 1371/journal. ppat. 0030087.
13. Coros A, DeConno E, Derbyshire KM (2008) Is6110, a mycobacterium tuberculosis complex-specific insertion sequence, is also present in the genome of mycobacterium smegmatis, suggestive of lateral gene transfer among mycobacterial species. J Bacteriol 190(9): 3408-3410. doi: JB. 00009-08[pii]10. 1128/JB. 00009-08.
14. de Steenwinkel JE, de Knegt GJ, ten Kate MT, van Belkum A, Verbrugh HA, Kremer K, van Soolingen D, Bakker-Woudenberg IA (2010) Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of mycobacterium tuberculosis. J Antimicrob Chemother 65(12): 2582-2589. doi: dkq374[pii]10. 1093/jac/dkq374.
15. Freeman L (1977) A set of measures of centrality based on betweenness. Sociometry 40: 35-41.
16. Gillespie SH (2001) Antibiotic resistance in the absence of selective pressure. Int J Antimicrob Agents 17(3): 171-176. doi: S0924-8579(00)00340-X[pii].
17. Gillespie SH (2002) Evolution of drug resistance in mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob Agents Chemother 46(2): 267-274.
18. Girvan M, Newman ME (2002) Community structure in social and biological networks. Proc Natl Acad Sci USA 99(12): 7821-7826. doi: 10. 1073/pnas. 12265379999/12/7821[pii].
19. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of atp-dependent transporters. Nat Rev Cancer 2(1): 48-58. doi: 10. 1038/nrc706.
20. Gupta AK, Katoch VM, Chauhan DS, Sharma R, Singh M, Venkatesan K, Sharma VD (2009) Microarray analysis of efflux pump genes in multidrug-resistant mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Microb Drug Resist 16(1): 21-28. doi: 10. 1089/mdr. 2009. 0054.
21. Gupta AK, Reddy VP, Lavania M, Chauhan DS, Venkatesan K, Sharma VD, Tyagi AK, Katoch VM (2010) Jefa (rv2459), a drug efflux gene in mycobacterium tuberculosis confers resistance to isoniazid and ethambutol. Indian J Med Res 132: 176-188.
22. Hegde SS, Vetting MW, Roderick SL, Mitchenall LA, Maxwell A, Takiff HE, Blanchard JS (2005) A fluoroquinolone resistance protein from mycobacterium tuberculosis that mimics DNA. Science 308(5727): 1480-1483. doi: 308/5727/1480[pii]10. 1126/science. 1110699.
23. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C (2009) String 8-a global view on proteins and their functional interactions in 630 organisms. Nucl Acids Res 37(supp 1): D412-D416. doi: 10. 1093/nar/gkn760.
24. Kurland CG, Canback B, Berg OG (2003) Horizontal gene transfer: a critical view. Proc Natl Acad Sci USA 100(17): 9658-9662. doi: 10. 1073/pnas. 16328701001632870100[pii].
25. Liu B, Pop M (2009) Ardb-antibiotic resistance genes database. Nucleic Acids Res 37 (Database issue): D443-447. doi: gkn656 [pii] 10. 1093/nar/gkn656.
26. Ma Z, Lienhardt C, McIlleron H, Nunn AJ, Wang X (2010) Global tuberculosis drug development pipeline: the need and the reality. Lancet 375(9731): 2100-2109. doi: S0140-6736(10)60395-9[pii]10. 1016/S0140-6736(10)60359-9.
27. McKeegan KS, Borges-Walmsley MI, Walmsley AR (2002) Microbial and viral drug resistance mechanisms. Trends Microbiol 10(10 Suppl): S8-S14. doi: S0966842X02024290[pii].
28. Nathanson E, Gupta R, Huamani P, Leimane V, Pasechnikov AD, Tupasi TE, Vink K, Jaramillo E, Espinal MA (2004) Adverse events in the treatment of multidrug-resistant tuberculosis: results from the dots-plus initiative. Int J Tuberc Lung Dis 8(11): 1382-1384.
29. Nguyen L, Thompson CJ (2006) Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm. Trends Microbiol 14(7): 304-312. doi: S0966-842X(06)00125-9[pii]10. 1016/j. tim. 2006. 05. 005.
30. O'Sullivan DM, Hinds J, Butcher PD, Gillespie SH, McHugh TD (2008) Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin. J Antimicrob Chemother 62(6): 1199-1202. doi: dkn387[pii]10. 1093/jac/dkn387.
31. Ouellet H, Podust LM, de Montellano PR (2008) Mycobacterium tuberculosis cyp130: crystal structure, biophysical characterization, and interactions with antifungal azole drugs. J Biol Chem 283(8): 5069-5080. doi: M708734200[pii]10. 1074/jbc. M708734200.
32. Pethe K, Swenson DL, Alonso S, Anderson J, Wang C, Russell DG (2004) Isolation of mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proc Natl Acad Sci USA 101(37): 13642-13647. doi: 10. 1073/pnas. 04016571010401657101[pii].
33. Protopopova M, Hanrahan C, Nikonenko B, Samala R, Chen P, Gearhart J, Einck L, Nacy CA (2005) Identification of a new antitubercular drug candidate, sq109, from a combinatorial library of 1, 2-ethylenediamines. J Antimicrob Chemother 56(5): 968-974. doi: dki319[pii]10. 1093/jac/dki319.
34. Raman K, Chandra N (2008) Mycobacterium tuberculosis interactome analysis unravels potential pathways to drug resistance. BMC Microbiol 8: 234. doi: 1471-2180-8-234[pii]10. 1186/1471-2180-8-234.
35. Raman K, Yeturu K, Chandra N (2008) Targettb: a target identification pipeline for mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst Biol 2: 109. doi: 1752-0509-2-109[pii]10. 1186/1752-0509-2-109.
36. Rawat R, Whitty A, Tonge PJ (2003) The isoniazid-nad adduct is a slow, tight-binding inhibitor of inha, the mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance. Proc Natl Acad Sci USA 100(24): 13881-13886. doi: 10. 1073/pnas. 22358481002235848100[pii].
37. Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, Murray MB (2009) Tuberculosis drug resistance mutation database. PLoS Med 6 (2): e2. doi: 08-PLME-HIA-2556 [pii] 10. 1371/journal. pmed. 1000002.
38. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11): 2498-2504. doi: 10. 1101/gr. 123930313/11/2498[pii].
39. Shenoi S, Friedland G (2009) Extensively drug-resistant tuberculosis: a new face to an old pathogen. Annu Rev Med 60: 307-320. doi: 10. 1146/annurev. med. 60. 053107. 103955.
40. Silva PE, Bigi F, Santangelo MP, Romano MI, Martin C, Cataldi A, Ainsa JA (2001) Characterization of p55, a multidrug efflux pump in mycobacterium bovis and mycobacterium tuberculosis. Antimicrob Agents Chemother 45(3): 800-804. doi: 10. 1128/AAC. 45. 3. 800-804. 2001.
41. Simon JW, Richard AS, Ken L, Laurent K, Robert CR, Gurdyal SB (2004) The use of microarray analysis to determine the gene expression profiles of mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis (Edinburgh, Scotland) 84 (3): 263-274.
42. Spies FS, da Silva PE, Ribeiro MO, Rossetti ML, Zaha A (2008) Identification of mutations related to streptomycin resistance in clinical isolates of mycobacterium tuberculosis and possible involvement of efflux mechanism. Antimicrob Agents Chemother 52(8): 2947-2949. doi: AAC. 01570-07[pii]10. 1128/AAC. 01570-07.
43. Verkhedkar KD, Raman K, Chandra NR, Vishveshwara S (2007) Metabolome based reaction graphs of m. Tuberculosis and m. Leprae: a comparative network analysis. PLoS One 2 (9): e881. doi: 10. 1371/journal. pone. 0000881.
44. WHO (2010) Multidrug and extensively drug-resistant tb (m/xdr-tb): 2010 global report on surveillance and response.
45. Wright GD (2007) The antibiotic resistome: the nexus of chemical and genetic diversity. Nat Rev Microbiol 5(3): 175-186. doi: nrmicro1614[pii]10. 1038/nrmicro1614.
46. Zhang Y (2005) The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol 45: 529-564.
47. Zhang S-L, Qi H, Qiu D-L, Li D-X, Zhang J, Du C-M, Wang G-B, Yang Z-R, Sun Q (2007) Genotypic analysis of multidrug-resistant mycobacterium tuberculosis isolates recovered from central china. Biochem Genet 45(3): 281-290. doi: 10. 1007/s10528-006-9074-6.